Clinical Development Early clinical studies supported once-daily dosing and favorable tolerability
| Nasdaq, accessed February 2, 2026, How CDMOs Can Use Patent Data to Win More Pharmaceutical Clients DrugPatentWatch, accessed February 2, 2026, Tirzepatide Ruling: Implications for Compounders in an Evolving Legal Landscape, accessed February 2, 2026,
We propose that the seemingly opposing roles of GSH in cell survival and cell death reflect the spatial, metabolic, and microenvironmental context in which GSH homeostasis is disrupted
GLP-1 medications can work well while you take them If patients stay on treatment, weight loss can be substantial
Symptoms may include dizziness or lightheadedness, mood changes, sweating, hunger, confusion, weakness, headache, rapid heartbeat, or feeling jittery